Literature DB >> 31346256

Correction: Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Keith Nykamp1, Michael Anderson1, Martin Powers1, John Garcia1, Blanca Herrera1, Yuan-Yuan Ho1, Yuya Kobayashi1, Nila Patil1, Janita Thusberg1, Marjorie Westbrook1, Scott Topper2.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 31346256      PMCID: PMC6944637          DOI: 10.1038/s41436-019-0624-9

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


Correction to: Genetics in Medicine19:2017; 10.1038/gim.2017.37, published online 11 May 2017 There were errors in the author listing such that consortium group of authors was not named individually. The corrected author list is: Sienna Aguilar, MS; Swaroop Aradhya, PhD, FACMG; Daniel Beltran, PhD; Brandon Bunker, PhD; Amy Daly, MS; Anne Deucher, MD; Tali Ekstein, MS; Ali Entezam, PhD; Karl Erhard, PhD; Ed Esplin MD, PhD, FACMG, FACP; Jennifer Fulbright, MS; Amy Fuller, MS; Kristen McDonald Gibson, PhD, FACMG; Tina Hambuch, PhD, FACMG; Rachel Harte, PhD; Christy Hartshorne, MS; Eden Haverfield, PhD, FACMG; Nastaran Heidari, PhD; Michelle Hogue, MS; Daniela Iacoboni, MS; Britt Johnson, PhD, FACMG; Hio Chung Kang, PhD; Rachel Lewis, PhD; Shiloh Martin, PhD; Sarah McCalmon, PhD; Scott Michalski, MS; Cindy Morgan, MS; Laura Murillo, PhD; Piper Nicolosi, PhD; Karen Ouyang, PhD, FACMG; Carolina Pardo, PhD; Rita Quintana, PhD; Marina Rabideau, MS; Darlene Riethmaier, MS; Amanda Stafford, PhD; Jackie Tahiliani, MS; Chris Tan, MS; S. Paige Taylor, PhD; Shu-Huei Wang, PhD; Hannah White, MS; Ian Wilson, PhD, FACMG; Tom Winder, PhD, FACMG; and Michelle K. Zeman, PhD.
  1 in total

1.  Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.

Authors:  Jessica Quinn; Vicki Modell; Britt Johnson; Sarah Poll; Swaroop Aradhya; Jordan S Orange; Fred Modell
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.